Hjem › Aterosklerose › Connecticut
Kliniske studier for Aterosklerose i Connecticut
5 studier for Aterosklerose søker deltakere på steder i Connecticut.
Byer i Connecticut
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Yale University School of Medicine Yale-New Haven Hospital (YNHH) - Smilow Cancer Hospital, New Haven
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Cardiology Associates of Fairfield County, P.C., Stamford
- Chase Medical Research, LLC, Waterbury
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07157774Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Greater Hartford Nephrology, LLC, Bloomfield
- Nephrology and Hypertension Associates PC, Middlebury
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Waterbury
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT07000357Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 17. des. 2025 · NCT02915198Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.